TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 3 | 10 | -8 | 7 | -23 | 0 | -2 |
| P | %wins | 100 | 100 | 0 | 100 | 0 | 60 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/15/23 16:30 | 2/13/23 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Shearman Mark S | MA | O | EVP,Chie | S | -27 | 9.67 | 0 | -3 | -4 | 66 | D | ||||||||||||||
6/16/22 16:15 | 6/15/22 | EDIT | Editas Medicine, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Shearman Mark S | MA | O | EVP,Chie | S | -52 | 10.06 | 0 | -5 | -7 | 68 | D | ||||||||||||||
12/18/18 19:58 | 12/14/18 | AGTC | Applied Genetic Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Shearman Mark S | FL | O | Chief Sc | S | -10 | 3.35 | 0 | -3 | -100 | 0 | D | ||||||||||||||
9/26/16 17:20 | 9/22/16 | AGTC | Applied Genetic Technologies Corp | DE | Health | BioPrd | Biological Products, (No Diag | Shearman Mark S | FL | O | Chief Sc | P | 27 | 8.87 | 3 | 3 | New | 3 | D | -49 | -35 | -34 | -34 | -42 | -28 | 1 | 2 | 3 | 10 | -8 | 7 | -23 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |